Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Véronique Mathieu

Showing results (1-10 of 105) with videos related to

Pageof 11
Sort By:
Oncotarget|January 18, 2012
Galectin-1 as an oncotarget in gliomas and melanomasFlorence Lefranc, Véronique Mathieu, Robert Kiss
World Journal of Biological Chemistry|September 28, 2011
Galectin-1-mediated biochemical controls of melanoma and glioma aggressive behaviorFlorence Lefranc, Véronique Mathieu, Robert Kiss
Neoplasia (New York, N.Y.)|October 26, 2005
Gastrin exerts pleiotropic effects on human melanoma cell biologyVéronique Mathieu, Tatjana Mijatovic, Marc van Damme, et al.
Translational Oncology|July 9, 2008
Amaryllidaceae isocarbostyril alkaloids and their derivatives as promising antitumor agentsLaurent Ingrassia, Florence Lefranc, Véronique Mathieu, et al.
Bioorganic & Medicinal Chemistry Letters|May 13, 2014
Synthesis and antiproliferative studies of 5-aryl-2-(3-thienylamino)-1,3,4-thiadiazolesGermain Revelant, Charlène Gadais, Véronique Mathieu, et al.
Brain Pathology (Zurich, Switzerland)|April 18, 2009
Galectins and gliomasMarie Le Mercier, Shannon Fortin, Véronique Mathieu, et al.
Journal of Medicinal Chemistry|March 23, 2013
Therapeutic agents triggering nonapoptotic cancer cell deathAlexander Kornienko, Véronique Mathieu, Shiva K Rastogi, et al.
Biomaterials|June 4, 2013
A review of the current status of siRNA nanomedicines in the treatment of cancerPauline Resnier, Tristan Montier, Véronique Mathieu, et al.
Chemmedchem|March 5, 2015
Synthesis and in vitro antiproliferative activity of amido and amino analogues of the marine alkaloid isogranulatimideHubert Lavrard, Béatrice Salvetti, Véronique Mathieu, et al.
Bioorganic & Medicinal Chemistry Letters|December 31, 2013
Growth inhibitory activity for cancer cell lines of lapachol and its natural and semi-synthetic derivativesSerena Fiorito, Francesco Epifano, Céline Bruyère, et al.
Pageof 11

Showing results (1-10 of 105) with videos related to

Sort By:
Pageof 11
Oncotarget|January 18, 2012
Galectin-1 as an oncotarget in gliomas and melanomasFlorence Lefranc, Véronique Mathieu, Robert Kiss
World Journal of Biological Chemistry|September 28, 2011
Galectin-1-mediated biochemical controls of melanoma and glioma aggressive behaviorFlorence Lefranc, Véronique Mathieu, Robert Kiss
Neoplasia (New York, N.Y.)|October 26, 2005
Gastrin exerts pleiotropic effects on human melanoma cell biologyVéronique Mathieu, Tatjana Mijatovic, Marc van Damme, et al.
Translational Oncology|July 9, 2008
Amaryllidaceae isocarbostyril alkaloids and their derivatives as promising antitumor agentsLaurent Ingrassia, Florence Lefranc, Véronique Mathieu, et al.
Bioorganic & Medicinal Chemistry Letters|May 13, 2014
Synthesis and antiproliferative studies of 5-aryl-2-(3-thienylamino)-1,3,4-thiadiazolesGermain Revelant, Charlène Gadais, Véronique Mathieu, et al.
Brain Pathology (Zurich, Switzerland)|April 18, 2009
Galectins and gliomasMarie Le Mercier, Shannon Fortin, Véronique Mathieu, et al.
Journal of Medicinal Chemistry|March 23, 2013
Therapeutic agents triggering nonapoptotic cancer cell deathAlexander Kornienko, Véronique Mathieu, Shiva K Rastogi, et al.
Biomaterials|June 4, 2013
A review of the current status of siRNA nanomedicines in the treatment of cancerPauline Resnier, Tristan Montier, Véronique Mathieu, et al.
Chemmedchem|March 5, 2015
Synthesis and in vitro antiproliferative activity of amido and amino analogues of the marine alkaloid isogranulatimideHubert Lavrard, Béatrice Salvetti, Véronique Mathieu, et al.
Bioorganic & Medicinal Chemistry Letters|December 31, 2013
Growth inhibitory activity for cancer cell lines of lapachol and its natural and semi-synthetic derivativesSerena Fiorito, Francesco Epifano, Céline Bruyère, et al.
Pageof 11